Home|Journals|Articles by Year

Directory for Medical Articles

Original Article

AJVS. 2017; 55(1): 152-161

Effect of Rosemary (Rosmarinus Officinalis) Dietary Supplementation in Broiler Chickens Concerning immunity, Antioxidant Status, and Performance

Safaa A. Ghozlan, Ali H. El-Far, Kadry M. Sadek, Abdelrahman A. Abourawash, Mervat A. Abdel-Latif.


This study was conducted to evaluate the effect of rosemary leaves on the growth performance, blood parameters, and immune response of broiler chickens by determination of the serum immunoglobulins (IgA, IgM, and IgG), interferon-γ (INF-γ) and interleukin-10 (IL-10). Also, malondialdehyde (MDA), total superoxide dismutase (T.SOD), glutathione S-transferase (GST), and glutathione reduced (GSH) levels in the thigh and breast muscles were determined to evaluate the effect of rosemary in the broiler chicken’s muscles. To achieve this aim, 120 Cobb of one-day-old chicks were allocated into four equal groups as a control group that supplemented by the basal diet, while the other three groups were fed basal diet supplemented with 0.5, 1.0, and 1.5% of rosemary. The data of growth performance indicated that supplementation of broiler with rosemary had no growth-promoting effects. Feeding diet with rosemary leaves meal significantly increased the serum total protein and globulin, while significantly decreased total cholesterol and triacylglycerol levels. Rosemary significantly increased the IgG, IgM, INF-γ, IL-10, and muscle GSH levels and T. SOD and GST activities. Whereas, muscle MDA levels were significantly decreased, so rosemary could be considered as a natural antioxidant in broiler diet. Concomitantly, provide a healthy broiler’s meat with less MDA that favorable to human consumption.

Key words: Broilers, Immunity, Antioxidant, Performance, Feed additives, Rosemary

Full-text options

Share this Article

Online Article Submission
• ejmanager.com

Review(er)s Central
About BiblioMed
License Information
Terms & Conditions
Privacy Policy
Contact Us

The articles in Bibliomed are open access articles licensed under the terms of the Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International License (https://creativecommons.org/licenses/by-nc-sa/4.0/) which permits unrestricted, non-commercial use, distribution and reproduction in any medium, provided the work is properly cited.